首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2763010篇
  免费   243911篇
  国内免费   33371篇
耳鼻咽喉   36255篇
儿科学   80879篇
妇产科学   65126篇
基础医学   455420篇
口腔科学   70117篇
临床医学   260168篇
内科学   457208篇
皮肤病学   76887篇
神经病学   237422篇
特种医学   107547篇
外国民族医学   225篇
外科学   420971篇
综合类   124973篇
现状与发展   95篇
一般理论   2032篇
预防医学   230500篇
眼科学   64037篇
药学   195232篇
  321篇
中国医学   23210篇
肿瘤学   131667篇
  2023年   16694篇
  2022年   33259篇
  2021年   66823篇
  2020年   44422篇
  2019年   65636篇
  2018年   76956篇
  2017年   59677篇
  2016年   64357篇
  2015年   83036篇
  2014年   119470篇
  2013年   181890篇
  2012年   84415篇
  2011年   82936篇
  2010年   120635篇
  2009年   124362篇
  2008年   62536篇
  2007年   61845篇
  2006年   74113篇
  2005年   70196篇
  2004年   66981篇
  2003年   57849篇
  2002年   46842篇
  2001年   58712篇
  2000年   50506篇
  1999年   61077篇
  1998年   63661篇
  1997年   62751篇
  1996年   59578篇
  1995年   55024篇
  1994年   48752篇
  1993年   45256篇
  1992年   37279篇
  1991年   34526篇
  1990年   31595篇
  1989年   32022篇
  1988年   29882篇
  1987年   28935篇
  1986年   27392篇
  1985年   28718篇
  1984年   31328篇
  1983年   30140篇
  1982年   35813篇
  1981年   34311篇
  1980年   32397篇
  1979年   23234篇
  1978年   24499篇
  1977年   23585篇
  1976年   21335篇
  1975年   18855篇
  1974年   17373篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
Introduction: Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype associated with an increased risk of recurrence and cancer-related death. Unlike hormone receptor-positive or HER2-positive breast cancers, there are limited targeted therapies available to treat TNBC and cytotoxic chemotherapy remains the mainstay of treatment. Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate targeting Trop-2 expressing cells and selectively delivering SN-38, an active metabolite of irinotecan.

Areas covered: This review covers the mechanism of action, safety and efficacy of sacituzumab govitecan in patients with previously treated, metastatic TNBC. Additionally, efficacy data in other epithelial malignancies is included based on a PubMed search for ‘sacituzumab govitecan’ and ‘clinical trial’.

Expert opinion: Sacituzumab govitecan has promising anti-cancer activity in patients with metastatic TNBC previously treated with at least two prior lines of systemic therapy based on a single arm Phase I/II clinical trial. A confirmatory Phase III randomized clinical trial is ongoing. Sacituzumab govitecan has a manageable side effect profile, with the most common adverse events being nausea, neutropenia, and diarrhea. The activity of sacituzumab govitecan likely extends beyond TNBC with promising early efficacy data in many other epithelial cancers, including hormone receptor-positive breast cancer.  相似文献   

22.
23.

Objectives

Expedient extubation after cardiac surgery has been associated with improved outcomes, leading to postoperative extubation frequently during overnight hours. However, recent evidence in a mixed medical-surgical intensive care unit population demonstrated worse outcomes with overnight extubation. This study investigated the impact of overnight extubation in a statewide, multicenter Society of Thoracic Surgeons database.

Methods

Records from 39,812 patients undergoing coronary artery bypass grafting or valve operations (2008-2016) and extubated within 24 hours were stratified according to extubation time between 06:00 and 18:00 (day) or between 18:00 and 6:00 (overnight). Outcomes including reintubation, mortality, and composite morbidity-mortality were evaluated using hierarchical regression models adjusted for Society of Thoracic Surgeons predictive risk scores. To further analyze extubation during the night, a subanalysis stratified patients into 3 groups: 06:00 to 18:00, 18:00 to 24:00, and 24:00 to 06:00.

Results

A total of 20,758 patients were extubated overnight (52.1%) and were slightly older (median age 66 vs 65 years, P < .001) with a longer duration of ventilation (4 vs 7 hours, P < .001). Day and overnight extubation were associated with equivalent operative mortality (1.7% vs 1.7%, P = .880), reintubation (3.7% vs 3.4%, P = .141), and composite morbidity-mortality (8.2% vs 8.0%, P = .314). After risk adjustment, overnight extubation was not associated with any difference in reintubation, mortality, or composite morbidity-mortality. On subanalysis, those extubated between 24:00 and 06:00 exhibited increased composite morbidity-mortality (odds ratio, 1.18; P = .001) but no difference in reintubation or mortality.

Conclusions

Extubation overnight was not associated with increased mortality or reintubation. These results suggest that in the appropriate clinical setting, it is safe to routinely extubate cardiac surgery patients overnight.  相似文献   
24.
25.
26.
27.
28.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support.  相似文献   
29.
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号